Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC)

LNG IUD as EC, IUD pain management, thrombosis risks with hormonal contraception, telehealth & medication abortion, adolescent contraception guidance

Cancer and contraception, menstrual cups and IUD displacement, vaginal microbiome and contraceptives, OTC birth control knowledge gaps, early medication abortion follow-up

Expanding Access to Injectable Contraception through Community Pharmacies

New and updated guidance on the initiation and management of contraception, including pain management options for IUD placement, support for DMPA-SQ, and new conditions and methods added.

Intrauterine mepivacaine for IUD placement, the impact of abortion restrictions on medical training, pregnancy of unknown location and very early medication abortion, and navigating abortion misinformation

Pain management during procedural abortion, serum etonogestrel levels not associated with mood changes during implant use, and clinical considerations when patients are traveling for abortion care.

COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!

Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.